推荐产品
方案
99.9%
表单
foil
制造商/商品名称
Goodfellow 078-442-49
电阻率
7.1 μΩ-cm, 0°C
长度 × 宽度 × 厚度
10 mm × 10 mm × 1.0 mm
沸点
3900 °C (lit.)
mp
2310 °C (lit.)
密度
12.45 g/cm3 (lit.)
SMILES字符串
[Ru]
InChI
1S/Ru
正在寻找类似产品? 访问 产品对比指南
1 of 4
此商品 | 810533 | 81053N | 810535 |
|---|---|---|---|
| assay ≥98.5% | assay ≥98% (purity) | assay ≥98% (purity) | assay ≥98% (purity) |
| technique(s) ELISA: suitable, western blot: suitable, Southern blotting: suitable | technique(s) blood typing: suitable ( ) | technique(s) blood typing: suitable ( ) | technique(s) blood typing: suitable ( ) |
| origin New Zealand origin | origin USA origin | origin USA origin | origin USA origin |
| biological source bovine | biological source bovine serum | biological source bovine serum | biological source bovine serum |
| Quality Level 100 | Quality Level 300 | Quality Level 300 | Quality Level 300 |
| form lyophilized | form lyophilized powder | form lyophilized powder | form lyophilized powder |
一般描述
For updated SDS information please visit www.goodfellow.com.
法律信息
Product of Goodfellow
储存分类代码
13 - Non Combustible Solids
WGK
nwg
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
A Bergamo et al.
Journal of inorganic biochemistry, 106(1), 90-99 (2011-11-25)
The study of metal complexes for the treatment of cancer diseases has resulted in the identification of some unique properties of ruthenium-based compounds. Among these inorganic-based agents, two of them, namely the ruthenium(III) drugs NAMI-A and KP1019 have undertaken with
Martin R Gill et al.
Chemical Society reviews, 41(8), 3179-3192 (2012-02-09)
In the last few decades, coordination complexes based on d(6) metal centres and polypyridyl ligand architectures been developed as structure- and site-specific reversible DNA binding agents. Due to their attractive photophysical properties, much of this research has focused on complexes
Aviva Levina et al.
Metallomics : integrated biometal science, 1(6), 458-470 (2009-11-01)
Interest in Ru anticancer drugs has been growing rapidly since NAMI-A ((ImH(+))[Ru(III)Cl(4)(Im)(S-dmso)], where Im = imidazole and S-dmso = S-bound dimethylsulfoxide) or KP1019 ((IndH(+))[Ru(III)Cl(4)(Ind)(2)], where Ind = indazole) have successfully completed phase I clinical trials and an array of other
E Tfouni et al.
Current medicinal chemistry, 17(31), 3643-3657 (2010-09-18)
The discovery of the involvement of nitric oxide (NO) in several physiological and pathophysiological processes launched a spectacular increase in studies in areas such as chemistry, biochemistry, and pharmacology. As a consequence, the development of NO donors or scavengers for
Elia Tfouni et al.
Nitric oxide : biology and chemistry, 26(1), 38-53 (2011-12-20)
Nitric oxide plays an important role in various biological processes, such as neurotransmission, blood pressure control, immunological responses, and antioxidant action. The control of its local concentration, which is crucial for obtaining the desired effect, can be achieved with exogenous
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
